Search by Drug Name or NDC
NDC 65862-0301-30 Emtricitabine 200 mg/1 Details
Emtricitabine 200 mg/1
Emtricitabine is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is EMTRICITABINE.
MedlinePlus Drug Summary
Emtricitabine is used along with other medications to treat human immunodeficiency virus (HIV) infection. Emtricitabine is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). It works by decreasing the amount of HIV in the blood. Although emtricitabine does not cure HIV, it may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. Taking these medications along with practicing safer sex and making other life-style changes may decrease the risk of transmitting (spreading) the HIV virus to other people.
Related Packages: 65862-0301-30Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Emtricitabine
Product Information
| NDC | 65862-0301 |
|---|---|
| Product ID | 65862-301_2bb2b403-2397-4c4d-a23f-666a58998bc3 |
| Associated GPIs | |
| GCN Sequence Number | 052802 |
| GCN Sequence Number Description | emtricitabine CAPSULE 200 MG ORAL |
| HIC3 | W5J |
| HIC3 Description | ANTIVIRALS, HIV-SPECIFIC, NUCLEOSIDE ANALOG, RTI |
| GCN | 20019 |
| HICL Sequence Number | 025426 |
| HICL Sequence Number Description | EMTRICITABINE |
| Brand/Generic | Generic |
| Proprietary Name | Emtricitabine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Emtricitabine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/1 |
| Substance Name | EMTRICITABINE |
| Labeler Name | Aurobindo Pharma Limited |
| Pharmaceutical Class | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA079188 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 65862-0301-30 (65862030130)
| NDC Package Code | 65862-301-30 |
|---|---|
| Billing NDC | 65862030130 |
| Package | 30 CAPSULE in 1 BOTTLE (65862-301-30) |
| Marketing Start Date | 2023-03-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |